Cite
HARVARD Citation
Sevigny, J. et al. (n.d.). O4‐04‐05: Aducanumab (BIIB037), an anti‐amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease: Interim results of a randomized, double‐blind, placebo‐controlled, phase 1b study. Alzheimer's & dementia. p. P277. [Online].